RecruitingNCT06681129
Study of Normal Intestinal Development and Disease in Premature and Term Neonates
Studying Necrotizing enterocolitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Amy O'Connell, MD, PhDBoston Children's Hospital
- Enrollment
- 100 target
- Eligibility
- 2 years · All sexes
- Timeline
- 2025 – 2034
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06681129 on ClinicalTrials.govOther trials for Necrotizing enterocolitis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07490834Long-term Nutritional Impact of Necrotizing Enterocolitis in Premature Newborns.Central Hospital, Nancy, France
- RECRUITINGNCT07192393Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).Imperial College London
- RECRUITINGNANCT06727877Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal MicrobiotaUniversity Hospital, Clermont-Ferrand
- ACTIVE NOT RECRUITINGNCT06850896Antibiotic Exposure on Gut Microbiota and Motility Establishment in NewbornsThe First Hospital of Jilin University
- RECRUITINGNCT07152106Amniotic Fluid & the Preterm GutMaxima Medical Center
- ACTIVE NOT RECRUITINGNANCT06908239Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm InfantsDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGNANCT06672913Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter StudyBaskent University Ankara Hospital
- RECRUITINGPHASE1, PHASE2NCT06315738Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing EnterocolitisNoveome Biotherapeutics, formerly Stemnion